Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Cash from Financing Activities (2022 - 2023)

Lexeo Therapeutics' Cash from Financing Activities history spans 2 years, with the latest figure at $100.1 million for Q4 2023.

  • For Q4 2023, Cash from Financing Activities rose 123644.44% year-over-year to $100.1 million; the TTM value through Dec 2023 reached $103.8 million, changed N/A, while the annual FY2024 figure was $88.8 million, 14.47% down from the prior year.
  • Cash from Financing Activities for Q4 2023 was $100.1 million at Lexeo Therapeutics, up from $3.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $100.1 million in Q4 2023 and bottomed at -$98000.0 in Q1 2023.